Biblio
Found 95 results
[ Author] Keyword Title Type Year Filters: Keyword is Alzheimer Disease [Clear All Filters]
“Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases.”, Neurobiol Aging, vol. 27, no. 8, pp. 1087-93, 2006.
, “Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure.”, Genome Med, vol. 10, no. 1, p. 43, 2018.
, “Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.”, Hum Mol Genet, vol. 12, no. 24, pp. 3259-67, 2003.
, “Covariate analysis of late-onset Alzheimer disease refines the chromosome 12 locus.”, Mol Psychiatry, vol. 11, no. 3, pp. 280-5, 2006.
, “A comprehensive genetic association study of Alzheimer disease in African Americans.”, Arch Neurol, vol. 68, no. 12, pp. 1569-79, 2011.
, “Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia.”, Hum Mol Genet, vol. 24, no. 12, pp. 3557-70, 2015.
, “Interaction between the alpha-T catenin gene (VR22) and APOE in Alzheimer's disease.”, J Med Genet, vol. 42, no. 10, pp. 787-92, 2005.
, “ANK1 is up-regulated in laser captured microglia in Alzheimer's brain; the importance of addressing cellular heterogeneity.”, PLoS One, vol. 12, no. 7, p. e0177814, 2017.
, “Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.”, Neurology, vol. 34, no. 7, pp. 939-44, 1984.
, “Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.”, Alzheimers Dement, vol. 13, no. 2, pp. 119-129, 2017.
, “The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable.”, Neurobiol Aging, vol. 41, pp. 115-121, 2016.
, “Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses.”, Alzheimers Dement, vol. 11, no. 12, pp. 1439-1451, 2015.
, “Association of apolipoprotein E genotype and Alzheimer disease in African Americans.”, Arch Neurol, vol. 63, no. 3, pp. 431-4, 2006.
, “Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD.”, Am J Med Genet B Neuropsychiatr Genet, vol. 124B, no. 1, pp. 29-37, 2004.
, “Analysis of pedigree data in populations with multiple ancestries: Strategies for dealing with admixture in Caribbean Hispanic families from the ADSP.”, Genet Epidemiol, vol. 42, no. 6, pp. 500-515, 2018.
, “Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.”, JAMA Neurol, vol. 71, no. 11, pp. 1394-404, 2014.
, “Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities.”, PLoS Genet, vol. 6, no. 9, p. e1001130, 2010.
, “Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 436-41, 2011.
, “Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.”, Neurogenetics, vol. 5, no. 4, pp. 201-8, 2004.
, “Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.”, Am J Med Genet B Neuropsychiatr Genet, vol. 136B, no. 1, pp. 62-8, 2005.
, “Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.”, Am J Epidemiol, vol. 146, no. 5, pp. 373-84, 1997.
, ,
“GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.”, Neuron, vol. 54, no. 5, pp. 713-20, 2007.
, “Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities.”, Expert Rev Mol Diagn, vol. 15, no. 3, pp. 339-48, 2015.
, “Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).”, Transl Psychiatry, vol. 3, p. e256, 2013.
,